Preliminary study of randomly-amplified polymorphic DNA analysis for typing extended-spectrum beta-lactamase (ESBL)-producing Klebsiella pneumoniae

Journal of the Medical Association of Thailand

Volumn 91, Issue 4, 2008, Pages 527-532

  Tribuddharat, Chanwit ^a   Srifuengfung, Somporn ^a   Chiangjong, Wararat ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

ESBL; Extended spectrum beta lactamase; Klebsiella pneumoniae; Randomly amplified polymorphic DNA; RAPD

Indexed keywords

EXTENDED SPECTRUM BETA LACTAMASE; PRIMER DNA;

ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; DISK DIFFUSION; DNA FINGERPRINTING; EPIDEMIC; HOSPITAL ADMISSION; HOSPITAL PATIENT; INTEGRON; KLEBSIELLA PNEUMONIAE; MOLECULAR EPIDEMIOLOGY; NONHUMAN; POLYMERASE CHAIN REACTION; RANDOM AMPLIFIED POLYMORPHIC DNA; SOUTHERN BLOTTING;

BACTERIAL TYPING TECHNIQUES; BETA-LACTAMASES; BLOTTING, SOUTHERN; DNA; GENE AMPLIFICATION; GENETIC SCREENING; GENOTYPE; HUMANS; HYBRIDIZATION, GENETIC; KLEBSIELLA PNEUMONIAE; POLYMORPHISM, GENETIC; RANDOM AMPLIFIED POLYMORPHIC DNA TECHNIQUE; TIME FACTORS;

EID: 44249119101     PISSN: 01252208     EISSN: 01252208     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Kusum M, Wongwanich S, Dhiraputra C, Pongpech P, Naenna P. Occurrence of extended-spectrum beta-lactamase in clinical isolates of Klebsiella pneumoniae in a University Hospital, Thailand. J Med Assoc Thai 2004; 87: 1029-33.
2. Turner PJ. Extended-spectrum beta-lactamases. Clin Infect Dis 2005; 41(Suppl 4): S273-5.
3. Rice L. Evolution and clinical importance of extended-spectrum beta-lactamases. Chest 2001; 119(Suppl 2): 391S-6S.
4. Shah AA, Hasan F, Ahmed S, Hameed A. Characteristics, epidemiology and clinical importance of emerging strains of Gram-negative bacilli producing extended-spectrum beta-lactamases. Res Microbiol 2004; 155: 409-21.
5. Jarlier V, Nicolas MH, Fournier G, Philippon A. Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis 1988; 10: 867-78.
6. Wu TL, Chia JH, Su LH, Kuo AJ, Chu C, Chiu CH. Dissemination of extended-spectrum beta-lactamase-producing Enterobacteriaceae in pediatric intensive care units. J Clin Microbiol 2003; 41: 4836-8.
7. Foxman B, Riley L. Molecular epidemiology: focus on infection. Am J Epidemiol 2001; 153: 1135-41.
8. Podschun R, Ullmann U. Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin Microbiol Rev 1998; 11: 589-603.
9. Riley LW. Molecular epidemiology of infectious disease-principle and practices. Washington, DC: ASM Press; 2004.
10. Gori A, Espinasse F, Deplano A, Nonhoff C, Nicolas MH, Struelens MJ. Comparison of pulsed-field gel electrophoresis and randomly amplified DNA polymorphism analysis for typing extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae. J Clin Microbiol 1996; 34: 2448-53.
11. Romero L, Lopez L, Rodriguez-Bano J, Ramon HJ, Martinez-Martinez L, Pascual A. Long-term study of the frequency of Escherichia coli and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases. Clin Microbiol Infect 2005; 11: 625-31.
12. Gniadkowski M. Evolution and epidemiology of extended-spectrum beta-lactamases (ESBLs) and ESBL-producing microorganisms. Clin Microbiol Infect 2001; 7: 597-608.
13. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing; Fifteenth Informational Supplement 2005; 25(1), M100-S15. Baltimore, Maryland: CLSI; 2005.
14. Williams JG, Kubelik AR, Livak KJ, Rafalski JA, Tingey SV. DNA polymorphisms amplified by arbitrary primers are useful as genetic markers. Nucleic Acids Res 1990; 18: 6531-5.
15. Mazurier SI, Wernars K. Typing of Listeria strains by random amplification of polymorphic DNA. Res Microbiol 1992; 143: 499-505.
16. Aufauvre-Brown A, Cohen J, Holden DW. Use of randomly amplified polymorphic DNA markers to distinguish isolates of Aspergillus fumigatus. J Clin Microbiol 1992; 30: 2991-3.
17. Tribuddharat C. The mechanisms of antibiotic resistance in Pseudomonas aeruginosa [thesis]. Chicago, IL: Finch University of Health Science The Chicago Medical School; 1999.
18. Heritage J, M'Zali FH, Gascoyne-Binzi D, Hawkey PM. Evolution and spread of SHV extended-spectrum beta-lactamases in gram-negative bacteria. J Antimicrob Chemother 1999; 44: 309-18.
19. Samaha-Kfoury JN, Araj GF. Recent developments in beta-lactamases and extended-spectrum beta-lactamases. BMJ 2003; 327: 1209-13.
20. Villegas MV, Correa A, Perez F, Miranda MC, Zuluaga T, Quinn JP. Prevalence and characterization of extended-spectrum beta-lactamases in Klebsiella pneumoniae and Escherichia coli isolates from Colombian hospitals. Diagn Microbiol Infect Dis 2004; 49: 217-22.
21. Chang CY, Chang LL, Chang YH, Lee TM, Chang SF. Characterisation of drug resistance gene cassettes associated with class 1 integrons in clinical isolates of Escherichia coli from Taiwan, ROC. J Med Microbiol 2000; 49: 1097-102.
22. Carattoli A. Importance of integrons in the diffusion of resistance. Vet Res 2001; 32: 243-59.
23. Dillon B, Thomas L, Mohmand G, Zelynski A, Iredell J. Multiplex PCR for screening of integrons in bacterial lysates. J Microbiol Methods 2005; 62: 221-32.
24. Leverstein-van Hall MA, HE MB, AR TD, Paauw A, Fluit AC, Verhoef J. Multidrug resistance among Enterobacteriaceae is strongly associated with the presence of integrons and is independent of species or isolate origin. J Infect Dis 2003; 187: 251-9.